December 06, 2025 17:30 ET | Source: Fulcrum Therapeutics, Inc. ― Clear dose-response observed, with a robust and clinically meaningful…
Inaugural Cohort in 2028, Cultivating Clinically Excellent and Technology-Savvy Doctors of the Future HONG KONG, Nov. 19, 2025 /PRNewswire/ -- With…
ST JULIAN'S, Malta, Nov. 19, 2025 /PRNewswire/ -- GBS Malta, part of GEDU Global Education, has today provided a boost…
YAKIMA, Wash., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Comprehensive Healthcare today announced that it was selected to Washington’s first Certified…
The formal safety review of Cohort 3 (5ug/kg/day) has been successfully completed with no safety or tolerability issues observed, allowing…
Media Release COPENHAGEN, Denmark; October 18, 2025 Updated data from the Phase 1/2 RAINFOL™-01 trial showed rinatabart sesutecan (Rina-S®) 100…
10 September 2025 – Ten athletes from every continent and 10 different sports have been announced as ambassadors for the…
ABU DHABI,UAE, Aug. 16, 2025 /PRNewswire/ -- Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) has welcomed its largest cohort…
NULISAseq™ CNS Disease Panel 120 and Inflammation Panel 250 to Power Biomarker Discovery in 23,000 Longitudinal Samples FREMONT, Calif., July…
New cohort embarks on a transformative journey in management and leadership MUMBAI, India, July 3, 2025 /PRNewswire/ -- Bhartiya Vidya Bhavan's…